Slava Zayats co-chairs the Antitrust Practice at Bates White. He has nearly 15 years of experience as an economist specializing in antitrust matters, with a particular focus on the healthcare industry. He leads economic analyses and has served as an expert in numerous merger and monopolization matters, including on behalf of the Federal Trade Commission and the Department of Justice (DOJ), insurers, providers, and other private entities. Many of his past engagements were complex antitrust matters that involved extensive discovery and data-intensive econometric analyses.
Dr. Zayats has also served as consulting expert to multiple state agencies, including the Massachusetts Health Policy Commission, the Massachusetts Attorney General’s office, and the California Department of Justice, advising on a broad range of antitrust and healthcare issues.
In addition to his extensive healthcare experience, Dr. Zayats has also conducted economic analyses on major engagements in other industries, including airlines, communications and media, retail, and asbestos. He has been published in the Antitrust Law Journal and the Review of Economics and Statistics.
PhD, Economics, University of North Carolina at Chapel Hill
BA, Economics, Belarus State Economic University
On behalf of the defendant and the intervenor in 21st Century Oncology v. State of Florida and Dr. Michael Katin (US District Court for the Northern District of Florida), supported the expert’s analysis regarding an economic basis for state policies, such as temporarily suspending non-compete enforceability, to prevent or ameliorate high concentration in physician services markets. The court denied the preliminary injunction, allowing the law to stand; the case subsequently settled.
Led the team that assisted the Department of Justice in evaluating the potential competitive effects of Sinclair Broadcast Group’s proposed acquisition of Tribune Media.
- On behalf of Wake Forest University Baptist Medical Center (WFBMC), assessed likely competitive effects of its proposed acquisition of High Point Regional Health.
- On behalf of Highmark Health, provided analysis to the Pennsylvania Insurance Department (PID) requesting modifications of certain conditions in the PID’s 2013 order, which was put in place following the creation of the Allegheny Health Network (AHN) via Highmark’s affiliation with the then-failing West Penn Allegheny Health System.
- On behalf of Humana in connection with its proposed merger with Aetna, co-led a Bates White team that provided support with responses to DOJ’s second request, analyzed likely competitive effects and barriers to entry and exit in the sale of Medicare Advantage products, and analyzed likely competitive effects in the sale of individual health insurance on public exchanges.
- Led the team that supported the expert work of Dr. Cory S. Capps on economic analysis of likely competitive effects and efficiencies in relation to Highmark Inc.’s proposed acquisition of Blue Cross of Northeastern Pennsylvania (BCNEPA).
Served as a consulting expert to the Massachusetts Health Policy Commission (HPC), an agency created in 2012 to increase value and access in the delivery of healthcare.
Co-authored a white paper that analyzed, on behalf of Dr. Oetker, the competitive effects of Dr. Oetker’s proposed acquisition of McCain Foods’ North American frozen pizza business.
Served as a consulting expert to the Massachusetts Attorney General’s office on the drivers of high healthcare costs in the State of Massachusetts.
Assisted Vermont-based Fletcher Allen Partners (FAP) in securing FTC clearance for FAP’s proposed affiliation with New York-based Community Providers, Inc. (CPI).
In In the Matter of OSF Healthcare System and Rockford Health System, directed economic and statistical analyses to support a testifying expert assessing, on behalf of the FTC, the competitive effects of OSF Healthcare System’s proposed acquisition of Rockford Health System in Rockford, Illinois.
In United States of America v. Blue Cross and Blue Shield of Montana, worked with a top-tier academic expert to analyze the competitive effects of the proposed transaction on behalf of the DOJ.
In In re Delta/AirTran Baggage Fee Antitrust Litigation, led economic and econometric analyses of class certification issues for two testifying experts on behalf of defendant AirTran in connection with an alleged conspiracy to reduce capacity in Atlanta and introduce a first-bag fee.
In Sheridan Healthcorp, Inc. v. AvMed Inc., supported a testifying expert on behalf of AvMed Health Plans, a Florida health insurer. Led economic analysis of market definition, market power, and competitive effects.
News & Insights
- January 3, 2017